Pulmonary Hypertension in Congenital Heart Disease

References

• Hoeper MM . Definition, classification, and epidemiology of pulmonary arterial hypertension . Semin. Respir. Crit. Care Med.30 ( 4 ), 369 – 375 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Vachiery JL , AdirY, BarberaJAet al. Pulmonary hypertension due to left heart diseases . J. Am. Coll. Cardiol.62 ( Suppl. 25 ), D100 – D108 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Galie N , HumbertM, VachieryJLet al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) . Eur. Respir. J.37 ( 1 ), 67 – 119 ( 2015 ).
   Google Scholar
• Diller GP , DimopoulosK, OkonkoDet al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication . Circulation112 ( 6 ), 828 – 835 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Duffels MG , EngelfrietPM, BergerRMet al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry . Int. J. Cardiol.120 ( 2 ), 198 – 204 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Engelfriet PM , DuffelsMG, MollerTet al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease . Heart93 ( 6 ), 682 – 687 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Farber HW , LoscalzoJ . Pulmonary arterial hypertension . N. Engl. J. Med.351 ( 16 ), 1655 – 1665 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Roberts KE , McelroyJJ, WongWPet al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease . Eur. Respir. J.24 ( 3 ), 371 – 374 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Harrison RE , BergerR, HaworthSGet al. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood . Circulation111 ( 4 ), 435 – 441 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Diller GP , KempnyA, InuzukaRet al. Survival prospects of treatment naive patients with Eisenmenger: a systematic review of the literature and report of own experience . Heart100 ( 17 ), 1366 – 1372 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Simonneau G , GalieN, RubinLJet al. Clinical classification of pulmonary hypertension . J. Am. Coll. Cardiol.43 ( Suppl. 12 ), S5 – S12 ( 2004 ).
   Web of Science ®Google Scholar
• Cossio-Aranda J , ZamoraKD, NandaNCet al. Echocardiographic correlates of severe pulmonary hypertension in adult patients with ostium secundum atrial septal defect . Echocardiography33 ( 12 ), 1891 – 1896 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Samaan HA . Surgery of ventricular septal defect and pulmonary vascular resistance . Thorax25 ( 6 ), 665 – 668 ( 1970 ).
   PubMed Web of Science ®Google Scholar
• De Vadder K , Van De BruaeneA, GewilligM, MeynsB, TroostE, BudtsW . Predicting outcome after Fontan palliation: a single-centre experience, using simple clinical variables . Acta Cardiol.69 ( 1 ), 7 – 14 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gewillig M , BrownSC, EyskensBet al. The Fontan circulation: who controls cardiac output? Interact. Cardiovasc. Thorac. Surg. 10 ( 3 ), 428 – 433 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kozlik-Feldmann R , HansmannG, BonnetD, SchranzD, ApitzC, Michel-BehnkeI . Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK . Heart102 ( Suppl. 2 ), ii42 – ii48 ( 2016 ).
   PubMedGoogle Scholar
• Diller GP , GatzoulisMA . Pulmonary vascular disease in adults with congenital heart disease . Circulation115 ( 8 ), 1039 – 1050 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Meyrick B , ReidL . Ultrastructural findings in lung biopsy material from children with congenital heart defects . Am. J. Pathol.101, 527 – 537 ( 1980 ).
   PubMed Web of Science ®Google Scholar
• Rabinovitch M . Molecular pathogenesis of pulmonary arterial hypertension . J. Clin. Invest.122 ( 12 ), 4306 – 4313 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Iacobazzi D , SuleimanMS, GhorbelM, GeorgeSJ, CaputoM, TullohRM . Cellular and molecular basis of RV hypertrophy in congenital heart disease . Heart102 ( 1 ), 12 – 17 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bradford R , TullohR . Diagnosis and management of pulmonary hypertension in adult congenital heart disease . Br. J. Cardiac Nurs.3, 138 – 145 ( 2008 ).
   Google Scholar
• Rubens C , EwertR, HalankMet al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension . Chest120 ( 5 ), 1562 – 1569 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Badesch DB , MclaughlinVV, DelcroixMet al. Prostanoid therapy for pulmonary arterial hypertension . J. Am. Coll. Cardiol.43 ( Suppl. 12 ), S56 – S61 ( 2004 ).
   Web of Science ®Google Scholar
• Christman BW , McphersonCD, NewmanJHet al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension . N. Engl. J. Med.327 ( 2 ), 70 – 75 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Breuer J , GeorgarakiA, SieverdingL, BadenW, ApitzJ . Increased turnover of serotonin in children with pulmonary hypertension secondary to congenital heart disease . Pediatr. Cardiol.17 ( 4 ), 214 – 219 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Cantor WJ , HarrisonDA, MoussadjiJSet al. Determinants of survival and length of survival in adults with Eisenmenger syndrome . Am. J. Cardiol.84 ( 6 ), 677 – 681 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Bonderman D , WexbergP, MartischnigAMet al. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension . Eur. Respir. J.37 ( 5 ), 1096 – 1103 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Paciocco G , MartinezFJ, BossoneE, PielstickerE, GillespieB, RubenfireM . Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension . Eur. Respir. J.17 ( 4 ), 647 – 652 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Miyamoto S , NagayaN, SatohTet al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing . Am. J. Respir. Crit. Care Med.161 ( 2 Pt 1 ), 487 – 492 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Van De Bruaene A , De MeesterP, VoigtJUet al. Worsening in oxygen saturation and exercise capacity predict adverse outcome in patients with Eisenmenger syndrome . Int. J. Cardiol.168 ( 2 ), 1386 – 1392 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kaemmerer HFS , BraunSL, KoellingKet al. Erythrocyte indexes, iron metabolism and hyperhomocysteinemia in adults with cysnotic congenital cardiac disease . Am. J. Cardiol.94, 825 – 828 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Van De Bruaene A , DelcroixM, PasquetAet al. Iron deficiency is associated with adverse outcome in Eisenmenger patients . Eur. Heart J.32 ( 22 ), 2790 – 2799 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• D’alto M , DimopoulosK, BudtsWet al. Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension . Heart102 ( 12 ), 910 – 918 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Post MC , JanssensS, Van De WerfF, BudtsW . Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension . Eur. Heart J.25 ( 18 ), 1651 – 1656 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Peacock AJ , CrawleyS, MclureLet al. Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study . Circ. Cardiovasc. Imaging7 ( 1 ), 107 – 114 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Swift AJ , RajaramS, CondliffeRet al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry . J. Cardiovasc. Magn. Reson.14, 40 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Shujaat A , BajwaAA, Al-SaffarF, BellardiniJ, JonesL, CuryJD . Diagnostic accuracy of echocardiography combined with chest CT in pulmonary hypertension . Clin. Respir. J.12 ( 3 ), 948 – 952 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Sandoval J , AguirreJS, PulidoTet al. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome . Am. J. Respir. Crit. Care Med.164 ( 9 ), 1682 – 1687 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Moncada S . Nitric oxide . J. Hypertens. Suppl.12 ( 10 ), S35 – S39 ( 1994 ).
   PubMedGoogle Scholar
• Galie N , BrundageBH, GhofraniHAet al. Tadalafil therapy for pulmonary arterial hypertension . Circulation119 ( 22 ), 2894 – 2903 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ghofrani HA , D’arminiAM, GrimmingerFet al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension . N. Engl. J. Med.369 ( 4 ), 319 – 329 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ghofrani HA , GalieN, GrimmingerFet al. Riociguat for the treatment of pulmonary arterial hypertension . N. Engl. J. Med.369 ( 4 ), 330 – 340 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hoeper MM , KlingerJR, BenzaRLet al. Rationale and study design of RESPITE: an open-label, Phase IIIB study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors . Respir. Med.122 ( Suppl. 1 ), S18 – S22 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Iglarz M , BinkertC, MorrisonKet al. Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist . J. Pharmacol. Exp. Ther.327 ( 3 ), 736 – 745 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Iglarz M , BossuA, WannerDet al. Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension . Life Sci.118 ( 2 ), 333 – 339 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Iglarz M , LandskronerK, BauerYet al. Comparison of macitentan and bosentan on right ventricular remodeling in a rat model of non-vasoreactive pulmonary hypertension . J. Cardiovasc. Pharmacol.66 ( 5 ), 457 – 467 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Rosenzweig EB , KersteinD, BarstRJ . Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects . Circulation99 ( 14 ), 1858 – 1865 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Hoeper MM , LeuchteH, HalankMet al. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension . Eur. Respir. J.28 ( 4 ), 691 – 694 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Boudjemline Y , PatelM, Malekzadeh-MilaniS, SzezepanskiI, LevyM, BonnetD . Patent ductus arteriosus stenting (transcatheter Potts shunt) for palliation of suprasystemic pulmonary arterial hypertension: a case series . Circ. Cardiovasc. Interv.6 ( 2 ), e18 – e20 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Baruteau AE , BelliE, BoudjemlineYet al. Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients . Eur. J. Cardiothorac. Surg.47 ( 3 ), e105 – e110 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Humbert M , MorrellNW, ArcherSLet al. Cellular and molecular pathobiology of pulmonary arterial hypertension . J. Am. Coll. Cardiol.43 ( 12 Suppl. ), S13 – S24 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Broberg C , UjitaM, Babu-NarayanSet al. Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger’s syndrome: a clinical dilemma . Heart90 ( 11 ), e63 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Shah P , WalterS, RoseV, KeithJD . Incidence of bacterial endocarditis in ventricular septal defects . Circulation34, 127 – 131 ( 1966 ).
   PubMed Web of Science ®Google Scholar
• Dajani AS , TaubertK, WilsonW, BolgerAFet al. Prevention of bacterial endocarditis: recommendations by the American Heart Association . Circulation96, 358 – 366 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Daliento L , SomervilleJ, PresbiteroP, MentiL, Brach-PreverS, RizzoliG, StoneS . Eisenmenger syndrome: factors relating to deterioration and death . Eur. Heart J.19, 1845 – 1855 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Arnott C , StrangeG, BullockAet al. Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome . Heart doi:10.1136/heartjnl-2017-311876 ( 2017 ) ( Epub ahead of print ).
   PubMedGoogle Scholar
• Herbert S , Gin-SingW, HowardL, TullohRM . Early experience of Macitentan for pulmonary arterial hypertension in adult congenital heart disease . Heart Lung Circ. doi:10.1016/j.hlc.2016.12.011 ( 2017 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Low AT , MedfordAR, MillarAB, TullohRM . Lung function in pulmonary hypertension . Respir. Med.109 ( 10 ), 1244 – 1249 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Galiè N , TorbickiA, BarstRet al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology . Eur. Heart J.25 ( 24 ), 2243 – 2278 ( 2004 ).
   PubMed Web of Science ®Google Scholar